REG - Eagle Capital Mgt. Aon PLC - Form 8.3 - [Aon Plc]

AonAnnouncement

29/04/2020 14:25

RNS Number : 3641L
  
Eagle Capital Management, LLC
  
29 April 2020
  
 

 
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


Eagle Capital Management, LLC
 




Company dealt in


Aon Plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.01 ordinary shares




Date of dealing


28 April 2020




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


6,234,169 (2.70%)


 




(2) Derivatives (other than options)


N/A


 




(3) Options and agreements to purchase/sell


N/A


 




Total


6,234,169 (2.70%)


 



 
 
 
 
 
 
 



 
(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) 




Class of relevant security:


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


N/A


 




 
(2) Derivatives (other than options)


N/A


 




 
(3) Options and agreements to purchase/sell


N/A


 




Total


N/A


 



 
 
 
 
 
 
 




 

 
3.       DEALINGS (Note 4) 
 
(a)      Purchases and sales
 




Purchase/sale


Number of relevant securities


Price per unit (Note 5)




BUY


53521


USD 174.34




SELL


112


USD 173.53




SELL


599


USD 173.54




SELL


1506


USD 174.36




SELL


2579


USD 174.42




SELL


108


USD 174.84




 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(Note 5)




N/A


 


 


 




 
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




N/A


 


 


 


 


 


 




 
 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




N/A


 


 




 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




N/A


 


 





 

 
4.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and 
any other person relating to the voting rights of any relevant securities under any option referred to 
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 
which any derivative referred to on this form is referenced. If none, this should be stated.
 
                                               
                                               NONE
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            NO
 




Date of disclosure


29 April 2020




Contact name


Mark Robertson




Telephone number


+1 212-293-4008




If a connected EFM, name of offeree/offeror with which connected


N/A




If a connected EFM, state nature of connection (Note 10)


N/A




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEPPUGPCUPUGWB